Coronary risk factors and their modification: Lipids, smoking, hypertension, estrogen, and the elderly

https://doi.org/10.1016/S0146-2806(06)80023-XGet rights and content

First page preview

First page preview
Click to open first page preview

References (193)

  • StamlerJ et al.

    Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)

    JAMA

    (1986)
  • PilgerE et al.

    Risk factors for peripheral atherosclerosis: retrospective evaluation by stepwise discriminant analysis

    Arteriosclerosis

    (1983)
  • TyrrellJ et al.

    Lipoprotein (a) and peripheral vascular disease

    J Intern Med

    (1992)
  • SalonenenR et al.

    Prevalence of carotid atherosclerosis and serum cholesterol levels in Eastern Finland

    Arteriosclerosis

    (1988)
  • BlankenhornDH et al.

    Beneficial effects of colestipol-niacin therapy on the common carotid artery: two-and four-year reduction of intima-media thickness measured by ultrasound

    Circulation

    (1993)
  • Trial of clofibrate in the treatment of ischaemic heart disease

    BMJ

    (1971)
  • PittB et al.

    Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC 1)

    J Am Coll Cardiol

    (1994)
  • GordonBR et al.

    Advances in LDL apheresis for the treatment of severe hypercholesterolemia

    Curr Opin Lipidol

    (1994)
  • CraigWY et al.

    Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data

    BMJ

    (1989)
  • ErnstE

    Fibrinogen: its emerging role as a cardiovascular risk factor

    Angiology

    (1994)
  • LuepkerRV

    Epidemiology of atherosclerotic diseases in population groups

  • Lipid Research Clinics Program

    The Lipid Research Clinics Primary Prevention Trial results

    JAMA

    (1984)
  • ManninenV et al.

    Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

    JAMA

    (1988)
  • RossouwJE et al.

    The value of lowering cholesterol after myocardial infarction

    N Engl J Med

    (1990)
  • SiegelD et al.

    Risk factor modification after myocardial infarction

    Ann Intern Med

    (1988)
  • CannerPL et al.

    Fifteen year mortality in coronary drug project patients: long-term benefits with niacin

    J Am Coll Cardiol

    (1980)
  • BrownG et al.

    Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

    N Engl J Med

    (1990)
  • Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    Lancet

    (1994)
  • CohenMV et al.

    Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected or proven coronary artery disease

    Circulation

    (1991)
  • BrownBG et al.

    Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease

    Circulation

    (1993)
  • FusterV et al.

    The pathogenesis of coronary artery disease and the acute coronary syndromes

    N Engl J Med

    (1992)
    FusterV et al.

    The pathogenesis of coronary artery disease and the acute coronary syndromes

    N Engl J Med

    (1992)
  • MacIsaacAL et al.

    Toward the quiescent coronary plaque

    J Am Coll Cardiol

    (1993)
  • BuchwaldH et al.

    Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

    N Engl J Med

    (1990)
  • KaneJP et al.

    Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens

    JAMA

    (1990)
  • WattsGF et al.

    Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS)

    Lancet

    (1992)
  • MorenoPR et al.

    Macrophage infiltration in acute coronary syndromes: implications for plaque rupture

    Circulation

    (1993)
  • SuperkoHR et al.

    Coronary artery disease regression: convincing evidence for the benefit of aggressive lipoprotein management

    Circulation

    (1994)
  • VaneJR et al.

    Regulatory function of the vascular endothelium

    N Engl J Med

    (1990)
  • VanhouttePM et al.

    Endothelium-derived relaxing factor and coronary vasospasm

    Circulation

    (1989)
  • VitaJA et al.

    Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis

    J Am Coll Cardiol

    (1989)
  • OsborneJA et al.

    Cardiovascular effects of acute hypercholesteroemia in rabbits: reversal with lovastatin treatment

    J Clin Invest

    (1989)
  • LeungW-H et al.

    Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

    Lancet

    (1993)
  • LaurentS et al.

    Flow-dependent vasodilation of brachial artery in essential hypertension

    Am J Physiol

    (1990)
  • CelemajerDS et al.

    Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults

    Circulation

    (1993)
  • CollinsP et al.

    Nitric oxide accounts for dose-dependant estrogen-mediated coronary relaxation after acute estrogen withdrawal

    Circulation

    (1994)
  • TreasureCB et al.

    Coronary endothelial responses are improved with aggressive lipid lowering therapy in patients with atherosclerosis

    Circulation

    (1993)
  • AndersonTJ et al.

    Cholesterol lowering therapy im- proves endothelial function in patients with coronary atherosclerosis

    Circulation

    (1993)
  • Cited by (17)

    • Disorders of Lipid Metabolism and Chronic Kidney Disease in the Elderly

      2009, Seminars in Nephrology
      Citation Excerpt :

      Thus, declining renal function in the elderly may increase the burden of cardiovascular risk. Approximately 33% of elderly men and 50% of elderly women have a total cholesterol level greater than 240.56 A greater prevalence of metabolic syndrome including central obesity with insulin resistance, increased blood pressure, and dyslipidemia characterized by increased triglyceride levels, small high dense LDL, and a low concentration of HDL is being noted in older adults.57,58

    • Relationship of time-activity-adjusted particle number concentration with blood pressure

      2018, International Journal of Environmental Research and Public Health
    View all citing articles on Scopus
    View full text